For these reasons, the addition of Vit.D to AI treatment could be doubly advantageous, both in counteracting the side effects at the bone level that occur during AI administration, and increasing the degree of aromatase suppression at the level of breast cancer cells and surrounding adipose tissue [16,39]. Here, CYP19A1 is linked to breast carcinoma.